Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb Co. (BMY) PT Lowered to $48 at BMO Capital

April 26, 2024 8:49 AM
BMO Capital analyst Evan David Seigerman lowered the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $48.00 (from $55.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Corporate News

Next Articles